100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Our Recommendation


WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)

WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)
Delivery by
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
Follow your doctor's guidance regarding the dose and duration of this medication. IB-Tib Capsule can be taken it with or without food, although it's advisable to take it consistently at the same time.
IB-Tib Capsule is a Bruton's tyrosine kinase inhibitor. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with IB-Tib Capsule . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Seek medical advice from your doctor: IB-Tib Capsule is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Doctor consultation is advised.
Caution Advised: IB-Tib Capsule should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Not Safe: IB-Tib Capsule may cause side effects which could affect your ability to drive.
Caution Advised: IB-Tib Capsule should be used with caution in patients with kidney disease. Dose adjustment of IB-Tib Capsule may be needed. Doctor consultation is advised.
Caution Advised: IB-Tib Capsule should be used with caution in patients with liver disease. Dose adjustment of IB-Tib Capsule may be needed. Doctor consultation is advised.
Sarkhej-Dholka Road, Bhat, Ahmedabad-382 210, INDIA.
Central Drugs Standard Control Organisation (CDSCO) (27 Mar. 2019)
Ibrutinib. Beerse Belgium: Janssen Pharmaceutica NV; (on 27 Mar. 2019)
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.